Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Infliximab-dyyb Biosimilar (Remsima)
Locations
1
Pakistan
Department of Dermatology, Services Institute of Medical Sciences/ Services Hospital
Lahore, Punjab Province, Pakistan
Start Date
November 6, 2023
Primary Completion Date
November 5, 2024
Completion Date
November 5, 2024
Last Updated
September 19, 2024
NCT03370133
NCT03598790
NCT05388916
Lead Sponsor
Services Institute of Medical Sciences, Pakistan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions